Skip to main content

Science + Tech

Cancer Drugs Offer Hope for Crohn’s Disease and Sarcoidosis
CLEVELAND - A new finding out in the December 1st issue of Genes & Development offers insight into a new treatment avenue for two painful inflammatory diseases: Crohn’s Disease and sarcoidosis. While the loss of NOD2, the gene studied in the provoking article, increases the risk of developing Crohn’...
Community Rallies to Fight Obesity in Cleveland’s Urban Youth
CLEVELAND - Cleveland’s childhood overweight and obesity rate is approximately 40 percent and show no sign of plateauing. A team of local researchers has set out to tackle the problem using a comprehensive and pioneering approach, which includes child and family behavioral interventions and partners...
Hyper-texting and Hyper-Networking Pose New Health Risks for Teens
CLEVELAND - Texting while driving can be a deadly combination for anyone. Yet, new data released today reveal that the dangers of excessive texting among teens are not limited to the road. Hyper-texting and hyper-networking are now giving rise to a new health risk category for this age group. Scott...
Case Western Reserve University Hosts National AWARE for All: Clinical Research Education Day for the Public on Saturday, November 6th
CLEVELAND – October 28, 2010 – Medical researchers say that the lack of clinical research volunteers is reaching crisis proportions and is rapidly becoming a major healthcare issue. In an effort to increase the health literacy in the Cleveland community, Case Western Reserve University, through the ...
Obesity Expert James Levine, MD, PhD, Appointed Chief of Endocrinology at UH Case Medical Center and Case Western Reserve University School of Medicine
CLEVELAND - Fred C. Rothstein, MD, President, University Hospitals Case Medical Center, and Pamela B. Davis, MD, PhD, Dean, Case Western Reserve University School of Medicine, announce the appointment of James Levine, MD, PhD, as Chief of the Division of Endocrinology in the Department of Medicine. ...
Case Western Reserve School of Medicine Researcher Discovers New “Anti-pathogenic” Drugs to Treat MRSA
CLEVELAND - Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) har...
New Dual Recognition Mechanism Discovered in Tuberculosis
CLEVELAND - One third of the world’s population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approac...
New Sporadic Prion Protein Disease Identified by Case Western Reserve
CLEVELAND - A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease (CJD) was reported in the 1920s. The landmark finding from the...
New Methods, New Math Speed Detection of Drug-resistant Malaria
CLEVELAND - Researchers at Case Western Reserve University developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drug...
Case Western Reserve School of Medicine Awarded $4.7M Contract from Defense Advanced Research Projects Agency
CLEVELAND - Jonathan Stamler, MD, Director of the Institute for Transformative Molecular Medicine and the Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation at the Case Western Reserve University and University Hospitals Harrington-McLaughlin Heart & V...